278 related articles for article (PubMed ID: 5755911)
1. Indications and limits of cardiac beta-receptor blockase: physiopharmacological and clinical considerations on the subject of beta-adrenergic receptor blockade, pure and otherwise.
Dotti F; Piva M; Ongari R
Arzneimittelforschung; 1968 Nov; 18(11):1445-8. PubMed ID: 5755911
[No Abstract] [Full Text] [Related]
2. [The beta-adrenolytics].
Nantel A
Union Med Can; 1968 Apr; 97(4):478-82. PubMed ID: 4386392
[No Abstract] [Full Text] [Related]
3. [Blocking of adrenergic beta-receptors. A new therapeutic principle].
Kusus T; Schnelle K; Lydtin H
Ther Ggw; 1968 Mar; 107(3):280 passim. PubMed ID: 4388462
[No Abstract] [Full Text] [Related]
4. [Therapeutic use of beta-receptor blocking agents].
Wallnöfer H; Bereitter E
Wien Klin Wochenschr; 1968 Apr; 80(15):288-92. PubMed ID: 5688615
[No Abstract] [Full Text] [Related]
5. [Alpha- and beta-receptors and their pharmacological influencing].
Gebhardt W
Med Klin; 1969 May; 64(18):822-6. PubMed ID: 4891559
[No Abstract] [Full Text] [Related]
6. [Blocking of adrenergic beta-receptors by means of drugs].
Dienstl F
Wien Z Inn Med; 1967; 48(10):377-400. PubMed ID: 4391011
[No Abstract] [Full Text] [Related]
7. Beta adrenergic blockade, 1972. Pharmacology and clinical uses.
Harrison DC
Am J Cardiol; 1972 Mar; 29(3):432-5. PubMed ID: 4400771
[No Abstract] [Full Text] [Related]
8. [Adrenergic beta-receptor blocking agents in the treatment of cardiothyreosis (arrhythmias, angina pectoris)].
Popovici D
Stud Cercet Endocrinol; 1969; 20(1):63-74. PubMed ID: 5343647
[No Abstract] [Full Text] [Related]
9. [Adrenergic beta blocking agents].
Policlinico Prat; 1969 May; 76(18):584-8. PubMed ID: 4396175
[No Abstract] [Full Text] [Related]
10. [Clinical value of beta-adrenergic receptor blocking agents].
Chmielewski T
Wiad Lek; 1970 Aug; 23(15):1317-20. PubMed ID: 4917574
[No Abstract] [Full Text] [Related]
11. Perspectives in adrenergic beta-receptor blockade.
Fitzgerald JD
Clin Pharmacol Ther; 1969; 10(3):292-306. PubMed ID: 4894830
[No Abstract] [Full Text] [Related]
12. [Effectiveness and limitations of adrenergic beta receptor blocking in the treatment of the stenocardia syndrome and of some disorders of cardiac rhythm: clinical trial with INPEA (N-isopropyl-p-mitrophenylethanolamine)].
Piva M; Ongari R; Dotti F
Clin Ter; 1968 Oct; 47(1):53-84. PubMed ID: 4393774
[No Abstract] [Full Text] [Related]
13. [Beta-adrenergic receptor blocking agents].
Hayase S; Ito H
Nihon Rinsho; 1970 Mar; 28 Suppl():680-3. PubMed ID: 4393440
[No Abstract] [Full Text] [Related]
14. [Beta-adrenergic receptor blockers in clinical practice].
Czuriga I; Edes I
Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
[TBL] [Abstract][Full Text] [Related]
15. [Beta-receptor-blocking agents and anesthesia].
Lydtin H
Med Welt; 1969 Aug; 35():1889-94. PubMed ID: 4390395
[No Abstract] [Full Text] [Related]
16. [Beta-adrenergic receptor blockaders].
Zhdanova NS; Liakishev AA
Ter Arkh; 1969 Mar; 41(3):10-21. PubMed ID: 4391123
[No Abstract] [Full Text] [Related]
17. [Anti-arrythmic effects of DL-propranolol, D-propranolol and I.C.I.50 172 in experimental myocardial infarction in dogs].
Staszewska-Barczak J
Acta Physiol Pol; 1970; 21(3):317-29. PubMed ID: 4393011
[No Abstract] [Full Text] [Related]
18. [Clinical use of beta adrenergic inhibiting agents in cardiovascular therapeutics].
Scebat L
Therapeutique; 1968 Nov; 44(9):560-4. PubMed ID: 4396094
[No Abstract] [Full Text] [Related]
19. [Clinical trial using the beta receptor blockader Visken].
Szám I; Holló J
Med Monatsschr; 1971 Sep; 25(9):425-8. PubMed ID: 4398675
[No Abstract] [Full Text] [Related]
20. [Adrenergetic beta-receptor-blocking agents].
Burckhardt D; Meier M
Praxis; 1969 Sep; 58(36):1121-3. PubMed ID: 5820385
[No Abstract] [Full Text] [Related]
[Next] [New Search]
